Schedule 13D ownership disclosure

Principia Biopharma Inc.

Security class unavailable · CUSIP: 74257L108

Event date: 2018-09-18

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
2,654,336
Percent of class
11.7000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000903423-18-000520
Form type
SC 13D
Filer
GSK plc
CIK
CIK 1131399
Filed
Sep 26, 2018
Reporting period
Sep 18, 2018
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub